Form 4 for OFIX Orthofix Medical Inc.

Accepted 2024-01-10 00:00:00 ET · period of report 2024-01-08 · accession 0001209191-24-001363 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-10	2024-01-08	OFIX	Kenny Kevin J.	Pres of Gbl Spine	F - Tax	$13.29	-1,511	145.8K	-1%	-$20.1K
D	2024-01-10	2024-01-08	OFIX	Kenny Kevin J.	Pres of Gbl Spine	M - OptEx	$0.00	+5,959	147.3K	+4%	$0
D	2024-01-10	2024-01-08	OFIX	Kenny Kevin J.	Pres of Gbl Spine	M - OptEx	$0.00	-5,959	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-08	F	D	1,511	$13.29	145,810	D	—	—
2	Common	Common Stock	2024-01-08	M	A	5,959	$0.00	147,321	D	—	—	(F1) On April 4, 2023, the reporting person was granted 5,959 performance-based restricted stock units (PSUs). Such PSUs vested and converted to common stock on a one-for-one basis on January 8, 2024.
3	Derivative	Performance Share Units	2024-01-08	M	D	5,959	$0.00	0	D	$0.00 · — to —	5,959 Common Stock	(F2) Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The synergy target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).